Literature DB >> 10698131

Endogenous opiates: 1998.

A L Vaccarino1, G A Olson, R D Olson, A J Kastin.   

Abstract

This paper is the twenty-first installment of our annual review of research concerning the opiate system. It summarizes papers published during 1998 that studied the behavioral effects of the opiate peptides and antagonists, excluding the purely analgesic effects, although stress-induced analgesia is included. The specific topics covered this year include stress; tolerance and dependence; eating and drinking; alcohol; gastrointestinal, renal, and hepatic function; mental illness and mood; learning, memory, and reward; cardiovascular responses; respiration and thermoregulation; seizures and other neurologic disorders; electrical-related activity; general activity and locomotion; sex, pregnancy, and development; immunologic responses; and other behaviors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698131     DOI: 10.1016/s0196-9781(99)00166-7

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  14 in total

1.  mu-Opioid receptors and limbic responses to aversive emotional stimuli.

Authors:  Israel Liberzon; Jon Kar Zubieta; Lorraine M Fig; K Luan Phan; Robert A Koeppe; Stephan F Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

Review 2.  Effects of exercise and physical activity on depression.

Authors:  P C Dinas; Y Koutedakis; A D Flouris
Journal:  Ir J Med Sci       Date:  2010-11-14       Impact factor: 1.568

3.  Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning.

Authors:  C L Patti; S R Kameda; R C Carvalho; A L Takatsu-Coleman; G B Lopez; S T Niigaki; V C Abílio; R Frussa-Filho; R H Silva
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

4.  Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system.

Authors:  Blandine Pommier; Françoise Beslot; Axelle Simon; Matthieu Pophillat; Toshimitsu Matsui; Valérie Dauge; Bernard P Roques; Florence Noble
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

5.  Effects of the Hybridization of Opioid and Neurotensin Pharmacophores on Cell Survival in Rat Organotypic Hippocampal Slice Cultures.

Authors:  Patrycja Kleczkowska; Maria Kawalec; Magdalena Bujalska-Zadrozny; Małgorzata Filip; Barbara Zablocka; Andrzej W Lipkowski
Journal:  Neurotox Res       Date:  2015-08-19       Impact factor: 3.911

6.  Panicolytic-like effects caused by substantia nigra pars reticulata pretreatment with low doses of endomorphin-1 and high doses of CTOP or the NOP receptors antagonist JTC-801 in male Rattus norvegicus.

Authors:  Juliana Almeida da Silva; Audrey Franceschi Biagioni; Rafael Carvalho Almada; Renato Leonardo de Freitas; Norberto Cysne Coimbra
Journal:  Psychopharmacology (Berl)       Date:  2017-08-30       Impact factor: 4.530

Review 7.  A new mechanism of synapse-specific neuronal plasticity.

Authors:  V P Nikitin
Journal:  Neurosci Behav Physiol       Date:  2007-07

8.  Stress-induced REM sleep increase is antagonized by naltrexone in rats.

Authors:  G Vázquez-Palacios; S Retana-Márquez; H Bonilla-Jaime; J Velázquez-Moctezuma
Journal:  Psychopharmacology (Berl)       Date:  2003-11-25       Impact factor: 4.530

9.  Effect of Aqueous Extract of Crocus sativus L. on Morphine-Induced Memory Impairment.

Authors:  Sayede Maryam Naghibi; Mahmoud Hosseini; Fatemeh Khani; Motahare Rahimi; Farzaneh Vafaee; Hassan Rakhshandeh; Azita Aghaie
Journal:  Adv Pharmacol Sci       Date:  2012-10-10

10.  A regulatory variation in OPRK1, the gene encoding the kappa-opioid receptor, is associated with alcohol dependence.

Authors:  Howard J Edenberg; Jun Wang; Huijun Tian; Sirisha Pochareddy; Xiaoling Xuei; Leah Wetherill; Alison Goate; Tony Hinrichs; Samuel Kuperman; John I Nurnberger; Marc Schuckit; Jay A Tischfield; Tatiana Foroud
Journal:  Hum Mol Genet       Date:  2008-03-04       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.